In contrast with such a result, two studies performed on SSc patients highlighted correlations between PTX3 and the presence or future development of vascular manifestations, including pitting scars, DUs, and PAH [89,90]. The gene discussed is PTX3; the disease is pulmonary arterial hypertension.